The effect of baby aspirin on reduction of edema and ecchymosis

Investigation the effect of baby aspirin on reduction of edema and ecchymosis in patients undergoing rhinoplasty

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180318039124N1

Enrollment

100

Registered

2018-03-24

Start date

2018-04-04

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty. Encounter for procedures for purposes other than remedying health state

Interventions

Intervention 1: Intervention group: Receiving 80 mg daily baby aspirin from the second day for 7 days. Intervention 2: Control group: Recieving daily baby aspirin pacebo from the second day for 7 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients candidate for rhinoplasty

Exclusion criteria

Exclusion criteria: Allergy to non-steroidal anti-inflammatory drugs (NSAIDs) Having coagulation disorders Having active infection Having a history of gastric ulcer or bleeding

Design outcomes

Primary

Measure	Time frame
Edema and ecchymosis. Timepoint: On post-operative days 3, 5, 7, 10 and 14. Method of measurement: 0-4 Point scoring tool.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDorna Karimi

Zahedan University of Medical Sciences

dor.karimi@zaums.ac.ir+98 54 3329 5715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026